The Omicron variant is expected to appear in New York state within several days, according to the state health commissioner. On Thursday, the second U.S. case of the variant was identified in Minnesota, in an individual who had just returned from New York City. (CNBC Weekly)
Novartis is spending $150 million in cash to purchase an experimental Parkinson’s drug from UCB. The deal is part of a larger Novartis plan to advance in the Parkinson’s sphere. (Endpoints News)
The Biden administration will require private health insurers to cover at-home COVID-19 tests. The policy is part of the administration’s efforts to curb an expected surge of winter cases. (Politico)
Researchers in Austria have developed human embryo models from stem cells. While synthetic embryology could allow scientists to better study human embryos, it comes with a host of ethical questions. (STAT)
In response to a need for culturally competent healthcare, more Black entrepreneurs are launching health-tech startups. The companies aim to target underserved communities, improve transportation and access services, and connect patients who may feel marginalized. (NPR)
